Podcast Episodes

Back to Search
The Implications of Recent Datasets for the Current and Future Management of Small Cell Lung Cancer — A 2024 World Conference on Lung Cancer Review
The Implications of Recent Datasets for the Current and Future Management of Small Cell Lung Cancer — A 2024 World Conference on Lung Cancer Review

Season 1

Dr Jacob Sands from the Dana-Farber Cancer Institute in Boston, Massachusetts, discusses recent presentations on approved and investigationa…

1 year, 4 months ago

Short Long
View Episode
Practical Perspectives: Optimizing Diagnosis and Treatment for Patients with Desmoid Tumors
Practical Perspectives: Optimizing Diagnosis and Treatment for Patients with Desmoid Tumors

Season 1

Dr Thierry Alcindor from Dana-Farber Cancer Institute in Boston, Massachusetts, and Dr Mrinal Gounder from Memorial Sloan Kettering Cancer C…

1 year, 4 months ago

Short Long
View Episode
Peripheral T-Cell Lymphoma
Peripheral T-Cell Lymphoma

Season 1

Dr Stephen Horwitz from Memorial Sloan Kettering Cancer Center in New York, New York, discusses management strategies for previously untreat…

1 year, 4 months ago

Short Long
View Episode
The Implications of Recent Datasets for the Current and Future Use of Nontargeted Therapy for Metastatic Non-Small Cell Lung Cancer
The Implications of Recent Datasets for the Current and Future Use of Nontargeted Therapy for Metastatic Non-Small Cell Lung Cancer

Season 1

Dr Edward Garon from UCLA Health Jonsson Comprehensive Cancer Center and Dr Luis Paz-Ares from the Spanish National Oncology Research Center…

1 year, 4 months ago

Short Long
View Episode
Meet The Professor: Optimizing the Management of Chronic Lymphocytic Leukemia — Part 1 of a 3-Part Series
Meet The Professor: Optimizing the Management of Chronic Lymphocytic Leukemia — Part 1 of a 3-Part Series

Season 1

Dr Matthew S Davids from Dana-Farber Cancer Institute in Boston, Massachusetts, reviews current available data and ongoing investigational t…

1 year, 4 months ago

Short Long
View Episode
The Implications of Recent Datasets for the Current and Future Management of Non-Small Cell Lung Cancer with Actionable Targets Beyond EGFR
The Implications of Recent Datasets for the Current and Future Management of Non-Small Cell Lung Cancer with Actionable Targets Beyond EGFR

Season 1

Dr Ibiayi Dagogo-Jack from Massachusetts General Hospital in Boston and Dr Corey J Langer from the Abramson Cancer Center in Philadelphia, P…

1 year, 5 months ago

Short Long
View Episode
The Implications of Recent Datasets for the Current and Future Management of Non-Small Cell Lung Cancer with EGFR Mutations
The Implications of Recent Datasets for the Current and Future Management of Non-Small Cell Lung Cancer with EGFR Mutations

Season 1

Dr Joshua K Sabari from the NYU Langone Health Perlmutter Cancer Center and Dr Helena Yu from Memorial Sloan Kettering Cancer Center in New …

1 year, 5 months ago

Short Long
View Episode
Optimizing the Management of Metastatic BRCA-Negative, Triple-Negative Breast Cancer
Optimizing the Management of Metastatic BRCA-Negative, Triple-Negative Breast Cancer

Season 1

Dr Tiffany Traina from the Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College in New York, New York, discusses optimiz…

1 year, 5 months ago

Short Long
View Episode
Striving for Consensus: Optimizing the Current and Future Management of Biliary Tract Cancers
Striving for Consensus: Optimizing the Current and Future Management of Biliary Tract Cancers

Season 1

Dr Lipika Goyal from Stanford Cancer Center in Palo Alto, California, Dr James J Harding from Memorial Sloan Kettering Cancer Center in New …

1 year, 5 months ago

Short Long
View Episode
Inside the Issue: Optimizing the Diagnosis and Treatment of Neuroendocrine Tumors
Inside the Issue: Optimizing the Diagnosis and Treatment of Neuroendocrine Tumors

Season 1

Dr Pamela Kunz from the Yale School of Medicine and Yale Cancer Center in New Haven, Connecticut, and Dr Simron Singh from the Odette Cancer…

1 year, 5 months ago

Short Long
View Episode

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us